SuperworthMinerva Neurosciences market cap NERV
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $109.8M
- Highest close in our data
- $560M
- May 2020
Minerva Neurosciences is worth $109.8M at the close on Oct 23, 2026, at $2.30 a share.
That is up 234% over the last year and up 84% over five years.
Its highest close in our data was $560M in May 2020.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $109.8M | $27.4M | $338.8M | +275% |
| 2025 | $29.3M | $9.6M | $32.9M | +85% |
| 2024 | $15.8M | $15.1M | $72.2M | −63% |
| 2023 | $43M | $8.5M | $67.8M | +407% |
| 2022 | $8.5M | $8.5M | $71.7M | −75% |
| 2021 | $34.2M | $34.2M | $153.2M | −66% |
| 2020 | $99.9M | $99.9M | $560M | −62% |
| 2019 | $264.6M | $159.2M | $336.8M | +2% |
| 2018 | $258.5M | $201.2M | $486.6M | +10% |
| 2017 | $234.1M | $201.2M | $419.4M | −43% |
| 2016 | $409M | $115.7M | $498.1M | +173% |
| 2015 | $150.1M | $80.8M | $157.7M | +47% |
| 2014 | $102M | $77.1M | $139.6M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Minerva Neurosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| NERVMinerva Neurosciences | $109.8M |
| LFVNLifevantage | $73.4M |
| SPROSpero Therapeutics | $64.6M |
| NATRNatures Sunshine Products | $213.8M |
| ATNMActinium Pharmaceuticals | $47.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| Peer median | $523.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Minerva Neurosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.